Onasemnogene Abeparvovec: A Review in Spinal Muscular Atrophy
In conclusion, onasemnogene abeparvovec represents an important treatment option for patients with SMA, particularly when initiated early in the course of the disease.
Source: CNS Drugs - Category: Neurology Source Type: research
More News: Adenoviruses | Brain | Children | Clinical Trials | Gene Therapy | Genetics | Motor Neurone Disease | Neurology | Prednisolone | Spinal Muscular Atrophy